OPENING BELL:
NIFTY FUTURE DOWN – 16.25 @ 8883.50S
BANKNIFTY FUTURE DOWN -91.25 @ 20540.00
USDINR @ 67.0700
NIFTY FUTURE:
S1-8870.87, S2-8824.53
R1- 8990.92, R2-9064.63
BANK NIFTY FUTURE:
S1 – 20489.17, S2-20347.08
R1- 20865.62, R2 21099.98
News Analysis by Tradebizz Research -
Tata Global Beverages extends partnership agreement with Keurig -
Tata Global Beverages (TGB) has expanded its partnership agreement with Keurig Green Mountain, Inc. (Keurig) for manufacturing, sales, licensing and distribution of the Eight O’Clock coffee and Tetley tea brands in K-Cup pods for use in Keurig brewers. This agreement allows for the continued success for the brands through in-home and away-from-home channels, as well as on Keurig’s consumer direct websites throughout the US and Canada.
Glenmark, Evestra enter into partnership agreement for generic Nuva Ring
Glenmark Pharmaceuticals Inc, USA (Glenmark) and Evestra Inc, have completed a strategic development, license and commercialization agreement to develop and market a generic version of Merck’s & Co’s NuvaRing product - etonogestrel/ethinyl estradiol vaginal ring - designed to allow women access to a more affordable birth control option. Development on the vaginal ring product is currently under way and the two companies expect to file an Abbreviated New Drug Application (ANDA) in fiscal 2019. Evestra will develop this product exclusively for Glenmark for the U.S. market.
NMDC fixes iron ore prices with effect from March 1
NMDC has fixed the prices of iron ore with effect from March 1, 2017. The prices of Lump Ore have been fixed to Rs 2,425 per WMT, while the prices of Fines have been fixed to Rs 2,185 per WMT. The above FOR prices are excluding Royalty, DMF, NMET, Cess, Forest Permit Fee etc.
USFDA issues warning letter to Wockhardt's US arm
U.S. Food and Drug Administration (USFDA) has issued a Warning Letter to Morton Grove Pharmaceuticals, USA, a step-down Subsidiary of Wockhardt. This would mean that current portfolio of the Company will continue to be made available in the market. However, new approvals will be withheld till resolution. The company, with the help of the Consultants, has already initiated appropriate measures since last several months to address the issues raised by USFDA.
For More Updates and News Click Here - http://www.tradebizzindia.com/freetrial
No comments:
Post a Comment